Çocuklarda Kalp Yetersizliği
Özet
Referanslar
Azak E, Ünsal H, Kibar AE, Çetin İE. Review: Congestive Heart Failure in Children. Turkish J Pediatr Dis. 2016; (10)3: 223-232.
Park, M. K., & Salamat, M. Park’s Pediatric Cardiology for Practitioners, (Seventh Edition), Philedelphia: Elsevier, 2021: Chapter 27; 346-356,
Watanabe K, Shih R. Update of Pediatric Heart Failure. Pediatr Clin North Am. 2020 Oct;67(5):889-901.
Myhre PL, Vaduganathan M, Claggett B, et al. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272.
Bekar L. Sakubitril/valsartan’ın kalp yetersizliğinde yarar sağlayan etki mekanizmaları nelerdir? Updates Cardiol 2020; 3(2):1-3
Shaddy R, Canter C, Halnon N, et al. Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). Am Heart J 2017; 193:23–34. 31.
McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726.
Del Castillo S, Shaddy RE, Kantor PF. Update on pediatric heart failure. Curr Opin Pediatr. 2019 Oct;31(5):598-603.
Yıldız İ, Karaböcüoğlu M, Sarımurat MN, Soysal A, Tutak E, Tunç T. Memorial pediatri uygulamaları, İstanbul: Ömür matbaacılık, 2021: bölüm III.4.C; 376-379 (3. Baskı).
Referanslar
Azak E, Ünsal H, Kibar AE, Çetin İE. Review: Congestive Heart Failure in Children. Turkish J Pediatr Dis. 2016; (10)3: 223-232.
Park, M. K., & Salamat, M. Park’s Pediatric Cardiology for Practitioners, (Seventh Edition), Philedelphia: Elsevier, 2021: Chapter 27; 346-356,
Watanabe K, Shih R. Update of Pediatric Heart Failure. Pediatr Clin North Am. 2020 Oct;67(5):889-901.
Myhre PL, Vaduganathan M, Claggett B, et al. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272.
Bekar L. Sakubitril/valsartan’ın kalp yetersizliğinde yarar sağlayan etki mekanizmaları nelerdir? Updates Cardiol 2020; 3(2):1-3
Shaddy R, Canter C, Halnon N, et al. Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). Am Heart J 2017; 193:23–34. 31.
McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726.
Del Castillo S, Shaddy RE, Kantor PF. Update on pediatric heart failure. Curr Opin Pediatr. 2019 Oct;31(5):598-603.
Yıldız İ, Karaböcüoğlu M, Sarımurat MN, Soysal A, Tutak E, Tunç T. Memorial pediatri uygulamaları, İstanbul: Ömür matbaacılık, 2021: bölüm III.4.C; 376-379 (3. Baskı).
